Evidence map›Paper›PMID 38414604›Full record

ArticleWorld journal of clinical cases2024

Abnormal uterine bleeding successfully treated

Toshiyuki Kakinuma, Kaoru Kakinuma, Rora Okamoto, Kaoru Yanagida, Michitaka Ohwada, Nobuhiro Takeshima

Open access · diamondAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in World journal of clinical cases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Toshiyuki KakinumaDepartment of Obstetrics and Gynecology, International University of Health and Welfare Hospital, Tochigi 329-2763, Japan. tokakinuma@gmail.com.
Kaoru KakinumaDepartment of Obstetrics and Gynecology, International University of Health and Welfare Hospital, Tochigi 329-2763, Japan.
Rora OkamotoDepartment of Obstetrics and Gynecology, International University of Health and Welfare Hospital, Tochigi 329-2763, Japan.
Kaoru YanagidaDepartment of Obstetrics and Gynecology, International University of Health and Welfare Hospital, Tochigi 329-2763, Japan.
Michitaka OhwadaDepartment of Obstetrics and Gynecology, International University of Health and Welfare Hospital, Tochigi 329-2763, Japan.
Nobuhiro TakeshimaDepartment of Obstetrics and Gynecology, International University of Health and Welfare Hospital, Tochigi 329-2763, Japan.
International University of Health and Welfare · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMicrowave endometrial ablation (MEA) is a minimally invasive treatment method for heavy menstrual bleeding. However, additional treatment is often required after recurrence of uterine myomas treated with MEA. Additionally, because this treatment ablates the endometrium, it is not indicated for patients planning to become pregnant. To overcome these issues, we devised a method for ultrasound-guided microwave ablation of uterine myoma feeder vessels. We report three patients successfully treated for heavy menstrual bleeding, secondary to uterine myoma, using our novel method. CASE SUMMARY: All patients had a favorable postoperative course, were discharged within 4 h, and experienced no complications. Further, no postoperative recurrence of heavy menstrual bleeding was noted. Our method also reduced the myoma's maximum diameter.

conclusionThis method does not ablate the endometrium, suggesting its potential application in patients planning to become pregnant.

Indexed as

Case reportDysmenorrheaFertility preservationHeavy menstrual bleedingMicrowaveUterine myoma

Identifiers

PMID38414604
PMCPMC10895625
OpenAlexW4392783038

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.